These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 35353745)
1. A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall? Fidani T; Desmarets G; Goupil J; Pouget JP; Boudousq V Clin Nucl Med; 2022 Jul; 47(7):640-643. PubMed ID: 35353745 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT. Agarwal KK; Shah D; Shah N; Mayank M Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192 [TBL] [Abstract][Full Text] [Related]
3. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126 [TBL] [Abstract][Full Text] [Related]
4. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346 [TBL] [Abstract][Full Text] [Related]
5. Radioembolization with Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107 [TBL] [Abstract][Full Text] [Related]
6. Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086 [TBL] [Abstract][Full Text] [Related]
7. Metabolic activity assessment by Kim DY; Lee HW; Kang W; Kim GM; Won JY; Yun M J Gastroenterol Hepatol; 2021 Jun; 36(6):1679-1684. PubMed ID: 33226706 [TBL] [Abstract][Full Text] [Related]
8. Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels. Ahmadzadehfar H; Pieper CC; Ezziddin S; Biersack HJ; Meyer C Clin Nucl Med; 2014 Mar; 39(3):305-7. PubMed ID: 24458185 [TBL] [Abstract][Full Text] [Related]
9. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET. Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354 [TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus. Zhang W; Fang C; Liu H; Chen Y Clin Nucl Med; 2019 Feb; 44(2):130-132. PubMed ID: 30562190 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT Imaging in Sarcomatoid Hepatocellular Carcinoma. Yang T; Zou MH; Zou Q; Jiao J; Zhang Y Clin Nucl Med; 2022 May; 47(5):427-429. PubMed ID: 35293354 [TBL] [Abstract][Full Text] [Related]
12. 90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT. Osborne DR; Acuff S; Neveu M; Kaman A; Syed M; Fu Y Clin Nucl Med; 2017 May; 42(5):373-374. PubMed ID: 28240669 [TBL] [Abstract][Full Text] [Related]
13. Focal Liver 18F-FDG Uptake in a Patient Who Underwent Thrombolysis for Brachiocephalic and Subclavian Thrombosis: A Potential Pitfall. Huot Daneault A; Le Blanc R; Voyer N; Turcotte É; Rousseau E Clin Nucl Med; 2021 Mar; 46(3):e173-e175. PubMed ID: 33181750 [TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma. Sun L; Wu H; Pan WM; Guan YS World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816 [TBL] [Abstract][Full Text] [Related]
15. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors. Obrzut S; McCammack K; Badran KW; Balistreri A; Ou E; Nguyen BJ; Hoh CK; Rose SC Clin Imaging; 2017; 42():43-49. PubMed ID: 27875761 [TBL] [Abstract][Full Text] [Related]
18. The forgotten place of radioembolization for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis. Levi Sandri GB; Lai Q; Lucatelli P Liver Int; 2017 Mar; 37(3):469-470. PubMed ID: 27886440 [No Abstract] [Full Text] [Related]
19. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT. Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753 [TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications. Gates VL; Salem R; Lewandowski RJ J Vasc Interv Radiol; 2013 Aug; 24(8):1153-5. PubMed ID: 23885913 [No Abstract] [Full Text] [Related] [Next] [New Search]